Sargent Bickham Lagudis LLC: MD position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Sargent Bickham Lagudis LLC on MD, newest first. How the timeline and the estimate are built.
Sargent Bickham Lagudis LLC held 568 MD shares at 2022-12-31 per its 13F-HR filed 2023-01-23.
the latest 13F is the newest step
- period ended2022-12-3113F 568 sharesChange vs previous 13F -1,704 shares
<0.01% of the 13F portfolio, value $8,440.
13F-HR 0001613939-23-000001 filed by Sargent Bickham Lagudis LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2022-09-3013F 2,272 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $38,000.
13F-HR 0001613939-22-000006 filed by Sargent Bickham Lagudis LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).